Efficacy and safety of voglibose in comparison with acarbose in type 2 diabetic patients

UK prospective diabetes study (UKPDS) group, Intensive blood glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet 352 (1998) 837–853. Ceriello, 1998, The emerging role of postprandial hyperglycemic spikes in the pathogenesis of diabetic complications, Diabetic Med., 15, 188, 10.1002/(SICI)1096-9136(199803)15:3<188::AID-DIA545>3.0.CO;2-V Temelkova-Kurktschiev, 2000, Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level, Diabetes Care, 23, 1830, 10.2337/diacare.23.12.1830 E.J. Bastyr III, C.A. Stuart, R.G. Brodows et al., for the IOEZ study group, Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c, Diabetes Care 23 (2000) 1236–1241. Owens, 2000, Increased prandial insulin secretion after administration of a single preprandial oral dose of repaglinide in patients with type 2 diabetes, Diabetes Care, 23, 518, 10.2337/diacare.23.4.518 Hirschberg, 2000, Improved control of mealtime glucose excursions with coadministration of nateglinide and metformin, Diabetes Care, 23, 349, 10.2337/diacare.23.3.349 Vannasaeng, 1995, Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulphonylurea and metformin in treatment of noninsulin dependent diabetes mellitus, J. Med. Assoc. Thailand, 78, 578 Deerochanawong, 1996, Efficacy of acarbose as monotherapy in NIDDM, J. Med. Assoc. Thailand, 79, 69 Matsuo, 1992, Effect of an intestinal disaccharase inhibitor (AO-128) on obesity and diabetes, Am. J. Clin. Nutr., 55, 314s, 10.1093/ajcn/55.1.314s Goke, 1995, Voglibose (AO-128) is an efficient α-glucosidase inhibitor and mobilizes the endogenous GLP-1 reserve, Digestion, 56, 493, 10.1159/000201282 Kawagishi, 1997, Relationship between gastric emptying and an α-glucosidase inhibitor effect on postprandial hyperglycemia in NIDDM patients, Diabetes Care, 20, 1529, 10.2337/diacare.20.10.1529 Matsumoto, 1998, Effects of voglibose on glycemic excursions, insulin secretion, and insulin sensitivity in non-insulin-treated NIDDM patients, Diabetes Care, 21, 256, 10.2337/diacare.21.2.256